Verjans et al (51) revealed that cytoplasmic MIF expression in tumor tissues was associated with improved survival in breast cancer patients, indicating that intracellular MIF may inhibit cell proliferation and indicate a favorable prognosis, whereas extracellular tumor tissue-derived MIF may be pro-inflammatory and may be associated with an unfavorable prognosis (51). The gene discussed is MIF; the disease is breast cancer.